SLR Investment Corp.

Previous wording

During the three months ended June 30, 2026, we invested approximately $202.4 million across 28 portfolio companies. This compares to investing approximately $333.3 million in 33 portfolio companies during the three months ended June 30, 2025. Investments sold, prepaid or repaid during the three months ended June 30, 2026 totaled approximately $210.7 million versus approximately $209.4 million for the three months ended June 30, 2025.

Current wording

During the three months ended September 30, 2026, we invested approximately $194.6 million across 32 portfolio companies. This compares to investing approximately $276.9 million in 33 portfolio companies during the three months ended September 30, 2025. Investments sold, prepaid or repaid during the three months ended September 30, 2026 totaled approximately $251.7 million versus approximately $311.9 million for the three months ended September 30, 2025.

Previous wording

At June 30, 2026, our portfolio consisted of 79 portfolio companies and was invested 21.2% in cash flow senior secured loans, 47.9% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 20.3% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 10.6% in life science investments, in each case, measured at fair value, versus 115 portfolio companies invested 24.6% in cash flow senior secured loans, 44.8% in asset-based senior secured loans / SLR Credit / SLR Healthcare ABL / SLR Business Credit, 19.1% in equipment senior secured financings / SLR Equipment / KBH, and 11.5% in life science investments, in each case, measured at fair value, at June 30, 2025.

Current wording

At September 30, 2026, our portfolio consisted of 77 portfolio companies and was invested 22.8% in cash flow senior secured loans, 45.7% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 21.0% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 10.5% in life science investments, in each case, measured at fair value, versus 109 portfolio companies invested 22.9% in cash flow senior secured loans, 46.2% in asset-based senior secured loans / SLR Credit / SLR Healthcare ABL / SLR Business Credit, 18.7% in equipment senior secured financings / SLR Equipment / KBH, and 12.2% in life science investments, in each case, measured at fair value, at September 30, 2025.

Previous wording

At June 30, 2026, 83.2%, or $1.68 billion, of our income producing investment portfolio* was floating rate and 16.8%, or $339.4 million, was fixed rate, measured at fair value. At June 30, 2025, 82.9%, or $1.75 billion, of our income producing investment portfolio* was floating rate and 17.1%, or $359.8 million, was fixed rate, measured at fair value. As of June 30, 2026 and 2025, we had two and one issuers, respectively, on non-accrual status.

Current wording

At September 30, 2026, 82.0%, or $1.62 billion, of our income producing investment portfolio* was floating rate and 18.0%, or $353.6 million, was fixed rate, measured at fair value. At September 30, 2025, 83.4%, or $1.74 billion, of our income producing investment portfolio* was floating rate and 16.6%, or $344.7 million, was fixed rate, measured at fair value. As of September 30, 2026 and 2025, we had two and one issuers, respectively, on non-accrual status.

Previous wording

As of June 30, 2026, SLR Credit had 31 funded commitments to 23 different issuers with total funded loans of approximately $328.7 million on total assets of $349.8 million. As of December 31, 2025, SLR Credit had 33 funded commitments to 26 different issuers with total funded loans of approximately $404.1 million on total assets of $420.7 million. As of June 30, 2026 and December 31, 2025, the largest loan outstanding totaled $32.4 million and $29.9 million, respectively. For the same periods, the average exposure per issuer was $14.3 million and $15.5 million, respectively. SLR Credit’s credit facility, which is non-recourse to the Company, had approximately $150.0 million and $215.8 million of borrowings outstanding at June 30, 2026 and December 31, 2025, respectively. For the three months ended June 30, 2026 and 2025, SLR Credit had net income of $3.4 million and $3.5 million, respectively, on gross income of $11.0 million and $12.5 million, respectively. For the six months ended June 30, 2026 and 2025, SLR

Current wording

As of September 30, 2026, SLR Credit had 32 funded commitments to 24 different issuers with total funded loans of approximately $425.9 million on total assets of $446.4 million. As of December 31, 2025, SLR Credit had 33 funded commitments to 26 different issuers with total funded loans of approximately $404.1 million on total assets of $420.7 million. As of September 30, 2026 and December 31, 2025, the largest loan outstanding totaled $38.3 million and $29.9 million, respectively. For the same periods, the average exposure per issuer was $17.7 million and $15.5 million, respectively. SLR Credit’s credit facility, which is non-recourse to the Company, had approximately $240.6 million and $215.8 million of borrowings outstanding at September 30, 2026 and December 31, 2025, respectively. For the three months ended September 30, 2026 and 2025, SLR Credit had net income (loss) of $1.2 million and ($1.7) million, respectively, on gross income of $9.5 million and $9.4 million, respectively. For the nine months ended September 30, 2026 and 2025, SLR Credit had net income of $7.6 million and $7.0 million, respectively, on gross income of $30.5 million and $32.0 million, respectively. Due to timing and non-cash items, there may be material differences between U.S. generally accepted accounting principles (“GAAP”) net income and cash available for distributions. As such, and subject to fluctuations in SLR Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Credit will be able to maintain consistent dividend payments to us.

Previous wording

As of June 30, 2026, SLR Equipment had 497 funded equipment-backed leases and loans to 248 different customers with a total net investment in leases and loans of approximately $324.9 million on total assets of $361.7 million. As of December 31, 2025, SLR Equipment had 485 funded equipment-backed leases and loans to 243 different customers with a total net investment in leases and loans of approximately $299.8 million on total assets of $338.3 million. As of June 30, 2026 and December 31, 2025, the largest position outstanding totaled $18.7 million and $17.8 million, respectively. For the same periods, the average exposure per customer was $1.3 million and $1.2 million, respectively. SLR Equipment’s credit facility, which is non-recourse to the Company, had approximately $244.2 million and $237.5 million of borrowings outstanding at June 30, 2026 and December 31, 2025, respectively. For the three months ended June 30, 2026 and 2025, SLR Equipment had net income of $4.3 million and $2.6 million, respectively, on gross income of $11.2 million and $8.8 million, respectively. For the six months ended June 30, 2026 and 2025, SLR Equipment had net income of $8.0 million and $0.6 million, respectively, on gross income of $21.3 million and $15.4 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Equipment’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Equipment will be able to maintain consistent dividend payments to us.

Current wording

As of September 30, 2026, SLR Equipment had 478 funded equipment-backed leases and loans to 241 different customers with a total net investment in leases and loans of approximately $330.3 million on total assets of $388.0 million. As of December 31, 2025, SLR Equipment had 485 funded equipment-backed leases and loans to 243 different customers with a total net investment in leases and loans of approximately $299.8 million on total assets of $338.3 million. As of September 30, 2026 and December 31, 2025, the largest position outstanding totaled $20.0 million and $17.8 million, respectively. For the same periods, the average exposure per customer was $1.4 million and $1.2 million, respectively. SLR Equipment’s credit facility, which is non-recourse to the Company, had approximately $54.7 million and $237.5 million of borrowings outstanding at September 30, 2026 and December 31, 2025, respectively. SLR Equipment had approximately $222.0 million of notes under the ABS structure payable at September 30, 2026. For the three months ended September 30, 2026 and 2025, SLR Equipment had net income of $1.9 million and $1.3 million, respectively, on gross income of $8.6 million and $6.0 million, respectively. For the nine months ended September 30, 2026 and 2025, SLR Equipment had net income of $9.9 million and $2.0 million, respectively, on gross income of $29.9 million and $21.4 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Equipment’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Equipment will be able to maintain consistent dividend payments to us.

Previous wording

As of June 30, 2026 and December 31, 2025, KBHT had total assets of $971.0 million and $940.3 million, respectively. For the same periods, debt recourse to KBHT totaled $312.2 million and $309.4 million, respectively, and non-recourse debt totaled $400.3 million and $407.8 million, respectively. None of the debt is recourse to the Company. For the three months ended June 30, 2026 and 2025, KBHT had net income (loss) of $(0.1) million and $2.9 million, respectively, on gross income of $177.5 million and $90.0 million, respectively. For the six months ended June 30, 2026 and 2025, KBHT had net income of $1.4 million and $6.2 million, respectively, on gross income of $248.3 million and $187.9 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.

Current wording

As of September 30, 2026 and December 31, 2025, KBHT had total assets of $1,041.6 million and $940.3 million, respectively. For the same periods, debt recourse to KBHT totaled $331.4 million and $309.4 million, respectively, and non-recourse debt totaled $417.3 million and $407.8 million, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2026 and 2025, KBHT had net income (loss) of $(2.5) million and $3.5 million, respectively, on gross income of $103.0 million and $87.4 million, respectively. For the nine months ended September 30, 2026 and 2025, KBHT had net income (loss) of ($1.2) million and $9.8 million, respectively, on gross income of $351.3 million and $275.4 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.

Previous wording

SLR Senior Investment Corp. (“SUNS”) acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and mid-sized companies operating in the healthcare industry. SUNS’s initial investment in SLR Healthcare ABL was approximately $32.8 million. The management team of SLR Healthcare co-invested in the transaction and continues to lead SLR Healthcare. As of June 30, 2026, SLR Healthcare’s management team and the Company owned approximately 8% and 92% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the SUNS acquisition on April 1, 2022. Effective with an amendment dated March 27, 2026, SLR Healthcare has a $160 million non-recourse credit facility, which is expandable to $300 million under its accordion facility. The maturity date of this facility is March 27, 2031.

Current wording

SLR Senior Investment Corp. (“SUNS”) acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and mid-sized companies operating in the healthcare industry. SUNS’s initial investment in SLR Healthcare ABL was approximately $32.8 million. The management team of SLR Healthcare co-invested in the transaction and continues to lead SLR Healthcare. As of September 30, 2026, SLR Healthcare’s management team and the Company owned approximately 9% and 91% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the SUNS acquisition on April 1, 2022. Effective with an amendment dated March 27, 2026, SLR Healthcare has a $160 million non-recourse credit facility, which is expandable to $300 million under its accordion facility. The maturity date of this facility is March 27, 2031.

Previous wording

SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2026, the portfolio totaled approximately $259.3 million of commitments with a total net investment in loans of $123.7 million on total assets of $133.4 million. As of December 31, 2025, the portfolio totaled approximately $297.8 million of commitments with a total net investment in loans of $157.0 million on total assets of $165.4 million. At June 30, 2026, the portfolio consisted of 48 issuers with an average balance of approximately $2.6 million versus 48 issuers with an average balance of approximately $3.3 million at December 31, 2025. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured, cash-pay loans. SLR Healthcare’s credit facility, which is non-recourse to us, had approximately $95.7 million and $127.2 million of borrowings outstanding at June 30, 2026 and December 31, 2025, respectively. For the three months ended June 30, 2026 and 2025, SLR Healthcare had net income of $1.3 million and $1.5 million, respectively, on gross income of $4.6 million and $5.8 million, respectively. For the six months ended June 30, 2026 and 2025, SLR Healthcare had net income of $3.1 million and $2.9

Current wording

SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2026, the portfolio totaled approximately $263.3 million of commitments with a total net investment in loans of $136.8 million on total assets of $146.1 million. As of December 31, 2025, the portfolio totaled approximately $297.8 million of commitments with a total net investment in loans of $157.0 million on total assets of $165.4 million. At September 30, 2026, the portfolio consisted of 45 issuers with an average balance of approximately $3.0 million versus 48 issuers with an average balance of approximately $3.3 million at December 31, 2025. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured, cash-pay loans. SLR Healthcare’s credit facility, which is non-recourse to us, had approximately $98.0 million and $127.2 million of borrowings outstanding at September 30, 2026 and December 31, 2025, respectively. For the three months ended September 30, 2026 and 2025, SLR Healthcare had net income of $1.3 million and $1.5 million, respectively, on gross income of $5.1 million and $6.0 million, respectively. For the nine months ended September 30, 2026 and 2025, SLR Healthcare had net income of $4.4 million and $4.4 million, respectively, on gross income of $15.2 million and $17.1 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Healthcare’s funded commitments, the timing of originations, and the repayment of financings, the Company cannot guarantee that SLR Healthcare will be able to maintain consistent dividend payments to us.

Previous wording

SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2026, the portfolio totaled approximately $925.8 million of commitments, of which, on a net basis, approximately $597.6 million were funded, on total assets of $642.9 million. As of December 31, 2025, the portfolio totaled approximately $920.4 million of commitments, of which $535.2 million were funded, on total assets of $574.1 million. At June 30, 2026, the portfolio consisted of 168 issuers with an average balance of approximately $3.6 million versus 179 issuers with an average balance of approximately $3.0 million at December 31, 2025. NMC has a senior credit facility with a bank lending group for $367.0 million, which expires on November 13, 2028. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is non-recourse to us, had approximately $325.6 million and $273.2 million of borrowings outstanding at June 30, 2026 and December 31, 2025, respectively. For the three months ended June 30, 2026 and 2025, SLR Business Credit had net income of $2.3 million and $2.9 million, respectively, on gross income of $12.7 million and $13.2 million, respectively. For the six months ended

Current wording

SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2026, the portfolio totaled approximately $882.7 million of commitments, of which, on a net basis, approximately $615.9 million were funded, on total assets of $652.5 million. As of December 31, 2025, the portfolio totaled approximately $920.4 million of commitments, of which $535.2 million were funded, on total assets of $574.1 million. At September 30, 2026, the portfolio consisted of 164 issuers with an average balance of approximately $3.8 million versus 179 issuers with an average balance of approximately $3.0 million at December 31, 2025. NMC has a senior credit facility with a bank lending group for $367.0 million, which expires on November 13, 2028. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is non-recourse to us, had approximately $336.6 million and $273.2 million of borrowings outstanding at September 30, 2026 and December 31, 2025, respectively. For the three months ended September 30, 2026 and 2025, SLR Business Credit had net income of $2.4 million and $2.5 million, respectively, on gross income of $15.4 million and $15.4 million, respectively. For the nine months ended September 30, 2026 and 2025, SLR Business Credit had net income of $6.7 million and $8.0 million, respectively, on gross income of $40.1 million and $41.6 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.

Previous wording

On May 4, 2026, our Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule 10b-18 of the Securities Exchange Act of 1934, as amended, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 7, 2027 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. There were no share repurchases during the three months ended June 30, 2026 or for the fiscal year ended December 31, 2025.

Current wording

On May 4, 2026, our Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule 10b-18 of the Securities Exchange Act of 1934, as amended, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 7, 2027 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. There were no share repurchases during the three and nine months ended September 30, 2026 or for the fiscal year ended December 31, 2025.

Previous wording

a rate of SOFR plus 2.15% (the “SSLP Facility”). SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2026 and December 31, 2025, borrowings outstanding on the SSLP Facility totaled $94.1 million and $94.5 million, respectively.

Current wording

a rate of SOFR plus 2.15% (the “SSLP Facility”). SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2026 and December 31, 2025, borrowings outstanding on the SSLP Facility totaled $87.8 million and $94.5 million, respectively.

Previous wording

three and six months ended June 30, 2026, SSLP invested $6.7 million and $16.5 million, respectively, in 5 and 7 portfolio companies, respectively. Investments sold or prepaid totaled $11.8 million and $15.2 million, respectively for the three and six months ended June 30, 2026. For the three and six months ended June 30, 2025, SSLP invested $32.3 million and $38.8 million, respectively, in 7 and 9 portfolio companies, respectively. Investments sold or prepaid totaled $13.9 million and $33.8 million, respectively for the three and six months ended June 30, 2025.

Current wording

As of September 30, 2026 and December 31, 2025, SSLP had total assets of $184.6 million and $192.8 million, respectively. For the same periods, SSLP’s portfolio consisted of 25 and 25 different portfolio companies, respectively. For the three and nine months ended September 30, 2026, SSLP invested $7.0 million and $23.5 million, respectively, in 6 and 10 portfolio companies, respectively. Investments sold or prepaid totaled $9.8 million and $25.0 million, respectively, for the three and nine months ended September 30, 2026. For the three and nine months ended September 30, 2025, SSLP invested $18.5 million and $57.4 million, respectively, in 4 and 11 portfolio companies, respectively. Investments sold or prepaid totaled $15.3 million and $49.0 million, respectively, for the three and nine months ended September 30, 2025.

Previous wording

Below is certain summarized financial information for SSLP as of June 30, 2026 and December 31, 2025 and for the three and six months ended June 30, 2026 and 2025:

Current wording

Below is certain summarized financial information for SSLP as of September 30, 2026 and December 31, 2025 and for the three and nine months ended September 30, 2026 and 2025:

Previous wording

The typically higher yields and interest rates on PIK securities, to the extent we invested, reflect the payment deferral and increased credit risks associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the loan-to-value ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on non-cash accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the three and six months ended June 30, 2026, capitalized PIK income totaled $1.7 million and $7.4 million, respectively. For the three and six months ended June 30, 2025, capitalized PIK income totaled $1.8 million and $3.5

Current wording

The typically higher yields and interest rates on PIK securities, to the extent we invested, reflect the payment deferral and increased credit risks associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the loan-to-value ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on non-cash accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the three and nine months ended September 30, 2026, capitalized PIK income totaled $2.1 million and $9.5 million, respectively. For the three and nine months ended September 30, 2025, capitalized PIK income totaled $1.9 million and $5.4 million, respectively.

Previous wording

Results comparisons for the three and six months ended June 30, 2026 and June 30, 2025 are presented below:

Current wording

Results comparisons for the three and nine months ended September 30, 2026 and September 30, 2025 are presented below:

Previous wording

respectively. The decrease in gross investment income for the year over year three month periods was primarily due to a decrease in size of the income-producing portfolio.

Current wording

For the three and nine months ended September 30, 2026, gross investment income totaled $49.3 million and $147.4 million, respectively. For the three and nine months ended September 30, 2025, gross investment income totaled $57.0 million and $164.1 million, respectively. The decrease in gross investment income for the year over year three month periods was primarily due to a decrease in size of the income-producing portfolio.

Previous wording

Net expenses totaled $31.1 million and $62.5 million, respectively, for the three and six months ended June 30, 2026, of which $11.6 million and $23.9 million, respectively, consisted of base management fees and performance-based incentive fees and $16.8 million and $33.2 million, respectively, consisted of interest and other credit facility expenses. Other general and administrative expenses totaled $2.7 million and $5.5 million, respectively, for the three and six months ended June 30, 2026. Over the same periods, $16 thousand and $30 thousand of performance-based incentive fees were waived. Net expenses totaled $32.3 million and $63.4 million, respectively, for the three and six months ended June 30, 2025, of which $13.2 million and $26.2 million, respectively, consisted of base management fees and performance-based incentive fees and $16.7 million and $32.6 million, respectively, consisted of interest and other credit facility expenses. Other general and administrative expenses totaled $2.4 million and $4.6 million, respectively, for the three and six months ended June 30, 2025. Over the same periods, $20 thousand and $22 thousand of performance-based incentive fees were waived. Expenses generally consist of management and performance-based incentive fees, interest and other credit facility expenses, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The decrease in expenses for the year over year three month and six month periods was primarily due to lower incentive fees on lower net investment income.

Current wording

Net expenses totaled $31.5 million and $94.0 million, respectively, for the three and nine months ended September 30, 2026, of which $11.6 million and $35.5 million, respectively, consisted of base management fees and performance-based incentive fees and $17.3 million and $50.4 million, respectively, consisted of interest and other credit facility expenses. Other general and administrative expenses totaled $2.6 million and $8.1 million, respectively, for the three and nine months ended September 30, 2026. Over the same periods, $7 thousand and $37 thousand of performance-based incentive fees were waived. Net expenses totaled $35.4 million and $98.7 million, respectively, for the three and nine months ended September 30, 2025, of which $13.4 million and $39.6 million, respectively, consisted of base management fees and performance-based incentive fees and $18.7 million and $51.3 million, respectively, consisted of interest and other credit facility expenses. Other general and administrative expenses totaled $3.3 million and $7.9 million, respectively, for the three and nine months ended September 30, 2025. Over the same periods, $13 thousand and $35 thousand of performance-based incentive fees were waived. Expenses generally consist of management and performance-based incentive fees, interest and other credit facility expenses, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The decrease in expenses for the year over year three month and nine month periods was primarily due to lower incentive fees on lower net investment income.

Previous wording

The Company’s net investment income totaled $17.8 million and $35.6 million, or $0.33 and $0.65, per average share, respectively, for the three and six months ended June 30, 2026. The Company’s net investment income totaled $21.6 million and $43.7 million, or $0.40 and $0.80, per average share, respectively, for the three and six months ended June 30, 2025.

Current wording

The Company’s net investment income totaled $17.8 million and $53.4 million, or $0.33 and $0.98, per average share, respectively, for the three and nine months ended September 30, 2026. The Company’s net investment income totaled $21.6 million and $65.3 million, or $0.40 and $1.20, per average share, respectively, for the three and nine months ended September 30, 2025.

Previous wording

The Company had investment sales and prepayments totaling approximately $211 million and $348 million, respectively, for the three and six months ended June 30, 2026. Net realized losses over the same periods were $152 thousand and $179 thousand, respectively. The Company had investment sales and prepayments totaling approximately $209 million and $406 million, respectively, for the three and six months ended June 30, 2025. Net realized gain (loss) over the same periods were $0.2 million and $(0.2) million,

Current wording

The Company had investment sales and prepayments totaling approximately $252 million and $600 million, respectively, for the three and nine months ended September 30, 2026. Net realized gain over the same periods were $307 thousand and $128 thousand, respectively. The Company had investment sales and prepayments totaling approximately $312 million and $718 million, respectively, for the three and nine months ended September 30, 2025. Net realized gains over the same periods were $1.3 million and $1.1 million,

Previous wording

respectively. Net realized loss for the three and six months ended June 30, 2026 and 2025 were primarily due to the disposition of selected assets.

Current wording

respectively. Net realized gain for the three and nine months ended September 30, 2026 and 2025 were primarily due to the disposition of selected assets.

Previous wording

For the three and six months ended June 30, 2026, net change in unrealized gain (loss) on the Company’s assets totaled ($9.3) million and ($10.0) million, respectively. Net unrealized loss for the three months ended June 30, 2026 was primarily due to depreciation in the value of our investments in Omniguide Holdings, Inc., iCIMS, Inc., RQM+ Corp. and SLR-AMI Topco Blocker LLC, among others, partially offset by appreciation in the value of our investments in Enhanced Permanent Capital, LLC, SLR Business Credit and SLR Equipment Finance, among others. Net unrealized loss for the six months ended June 30, 2026 was primarily due to depreciation in the value of our investments in Omniguide Holdings, Inc., RQM+ Corp., iCIMS, Inc., SLR-AMI Topco Blocker LLC and SLR Senior Lending Program LLC, among others, partially offset by appreciation in the value of our investments in SLR Business Credit, KBH Topco LLC, SLR Equipment Finance and Enhanced Permanent Capital, LLC, among others. For the three and six months ended June 30, 2025, net change in unrealized gain on the Company’s assets totaled $2.4 million and $0.6 million, respectively. Net unrealized gain for the three months ended June 30, 2025 was primarily due to appreciation in the value of our investments in KBH Topco, LLC, DeepIntent, Inc., SLR Business Credit and Bayside Parent, LLC, among others,

Current wording

For the three and nine months ended September 30, 2026, net change in unrealized gain (loss) on the Company’s assets totaled ($10.5) million and ($20.6) million, respectively. Net unrealized loss for the three months ended September 30, 2026 was primarily due to depreciation in the value of our investments in OmniGuide Holdings, Inc. and RQM+ Corp., among others, as well as the reversal of previously recognized unrealized appreciation upon the exit of our investment in Enhanced Permanent Capital, LLC, partially offset by appreciation in the value of our investments in SLR Business Credit, SLR-AMI Topco Blocker LLC and SLR Equipment Finance, among others. Net unrealized loss for the nine months ended September 30, 2026 was primarily due to depreciation in the value of our investments in OmniGuide Holdings, Inc., RQM+ Corp., iCIMS, Inc. and SLR Senior Lending Program LLC, among others, partially offset by appreciation in the value of our investments in SLR Business Credit, SLR Equipment Finance, KBH Topco LLC and SLR Healthcare ABL, among others. For the three and nine months ended September 30, 2025, net change in unrealized gain on the Company’s assets totaled $0.4 million and $1.0 million, respectively. Net unrealized gain for the three months ended September 30, 2025 was primarily due to appreciation in the value of our investments in SLR Business Credit, KBH Topco, LLC, SLR-AMI Topco Blocker LLC, Arcutis Biotherapeutics, Inc., Bayside Parent, LLC and Cerapedics, Inc., among others, partially offset by depreciation in the value of our investments in SLR Credit Solutions, SLR Equipment Finance and RQM+

Previous wording

partially offset by depreciation in the value of our investments in SLR Equipment Finance, OmniGuide Holdings, Inc., SLR-AMI

Current wording

Corp., among others, as well as the reversal of previously recognized unrealized appreciation upon the refinance of our investment in DeepIntent, Inc. Net unrealized gain for the nine months ended September 30, 2025 was primarily due to appreciation in the value of our investments in KBH Topco, LLC, SLR Business Credit, Bayside Parent, LLC, Arcutis Biotherapeutics, Inc., Cerapedics, Inc. and Centinel Spine LLC, among others, partially offset by depreciation in the value of our investments in SLR Equipment Finance, SLR Credit Solutions, SLR-AMI Topco Blocker, LLC, RQM+ Corp., OmniGuide Holdings, Inc., SOINT, LLC and SLR Senior Lending Program LLC, among others, as well as the reversal of previously recognized unrealized appreciation upon the exit of our investments in Outset Medical, Inc. and Retina Midco, Inc.

Previous wording

For the three and six months ended June 30, 2026, the Company had a net increase in net assets resulting from operations of $8.3 million and $25.4 million, respectively. For the same periods, earnings per average share were $0.15 and $0.47, respectively. For the three and six months ended June 30, 2025, the Company had a net increase in net assets resulting from operations of $24.2 million and $44.2 million, respectively. For the same periods, earnings per average share were $0.44 and $0.81, respectively.

Current wording

For the three and nine months ended September 30, 2026, the Company had a net increase in net assets resulting from operations of $7.6 million and $33.0 million, respectively. For the same periods, earnings per average share were $0.14 and $0.60, respectively. For the three and nine months ended September 30, 2025, the Company had a net increase in net assets resulting from operations of $23.3 million and $67.5 million, respectively. For the same periods, earnings per average share were $0.43 and $1.24, respectively.

Previous wording

The Company’s liquidity and capital resources are generated and generally available through its Credit Facility and SPV Credit Facility (as defined below), the 2026 Unsecured Notes, the 2027 Unsecured Notes, the 2027 Series F Unsecured Notes, the 2027 Series G Unsecured Notes, the 2028 Series H Unsecured Notes, the 2028 Series I Unsecured Notes and the 2028 Series J Unsecured Notes (collectively the “Debt Instruments”), through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic follow-on equity and/or debt offerings. As of June 30, 2026, we had a total of $465.4 million of collective unused borrowing capacity under the Credit Facility and SPV Credit Facility, subject to borrowing base limits.

Current wording

The Company’s liquidity and capital resources are generated and generally available through its Credit Facility and SPV Credit Facility (as defined below), the 2026 Unsecured Notes, the 2027 Unsecured Notes, the 2027 Series F Unsecured Notes, the 2027 Series G Unsecured Notes, the 2028 Series H Unsecured Notes, the 2028 Series I Unsecured Notes and the 2028 Series J Unsecured Notes (collectively the “Debt Instruments”), through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic follow-on equity and/or debt offerings. As of September 30, 2026, we had a total of $510.4 million of collective unused borrowing capacity under the Credit Facility and SPV Credit Facility, subject to borrowing base limits.

Previous wording

For the three and six months ended June 30, 2026 and 2025, the Company sold no shares of common stock under the Equity Distribution Agreement. As of June 30, 2026, shares representing $150.0 million of our common stock remain available for issuance and sale under the Equity Distribution Agreement.

Current wording

For the three and nine months ended September 30, 2026 and 2025, the Company sold no shares of common stock under the Equity Distribution Agreement. As of September 30, 2026, shares representing $150.0 million of our common stock remain available for issuance and sale under the Equity Distribution Agreement.

Previous wording

On August 16, 2024, the Company closed on Amendment No. 3 to its August 28, 2019 senior secured credit agreement (as amended to date, the “Credit Facility”). Following this amendment and several commitment increases between the fourth quarter of 2024 and the second quarter of 2026 and a commitment decrease in the fourth quarter of 2025 related to a lender who did not extend their commitment with Amendment No. 3, the Credit Facility is now composed of $720.0 million of revolving credit and $146.6 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of 1.75%-2.00% or the alternate base rate plus 0.75%-1.00%. The Credit Facility has a 0% floor, matures in August 2029 and includes ratable amortization in the final year. Subsequent to Amendment No. 4 on December 3, 2024, the Credit Facility may be increased up to $900 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that, among other things, require the Company to maintain a minimum stockholder’s equity and a minimum asset coverage ratio. At June 30, 2026, outstanding USD equivalent borrowings under the Credit Facility totaled $552.1 million, composed of $405.5 million of revolving credit and $146.6 million of term loans.

Current wording

On August 16, 2024, the Company closed on Amendment No. 3 to its August 28, 2019 senior secured credit agreement (as amended to date, the “Credit Facility”). Following this amendment and several commitment increases between the fourth quarter of 2024 and the second quarter of 2026 and a commitment decrease in the fourth quarter of 2025 related to a lender who did not extend their commitment with Amendment No. 3, the Credit Facility is now composed of $720.0 million of revolving credit and $143.3 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of 1.75%-2.00% or the alternate base rate plus 0.75%-1.00%. The Credit Facility has a 0% floor, matures in August 2029 and includes ratable amortization in the final year. Subsequent to Amendment No. 4 on December 3, 2024, the Credit Facility may be increased up to $900 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that, among other things, require the Company to maintain a minimum stockholder’s equity and a minimum asset coverage ratio. At September 30, 2026, outstanding USD equivalent borrowings under the Credit Facility totaled $503.8 million, composed of $360.5 million of revolving credit and $143.3 million of term loans.

Previous wording

We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time to time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on the Credit Facility, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose are excluded from total assets for purposes of computing the asset base upon which the management fee is determined. As of June 30, 2026 and December 31, 2025, we held face amounts of $400 million and $350 million, respectively, in cash equivalents.

Current wording

We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time to time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on the Credit Facility, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose are excluded from total assets for purposes of computing the asset base upon which the management fee is determined. As of September 30, 2026 and December 31, 2025, we held face amounts of $460 million and $350 million, respectively, in cash equivalents.

Previous wording

As of June 30, 2026, we had a total of $465.4 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.

Current wording

As of September 30, 2026, we had a total of $510.4 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.

Previous wording

The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of June 30, 2026, asset coverage was 184.7%.

Current wording

The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2026, asset coverage was 187.5%.

Previous wording

The Investment Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole or in part, with ours. For example, the Investment Adviser presently serves as investment adviser to SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured loans, including non-traditional asset-based loans and first lien loans, SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and SLR Private Credit BDC II LLC, an unlisted BDC focused on first lien senior secured floating rate loans. In addition, Mr. Gross, our Chairman, Co-Chief Executive Officer and President, Mr. Spohler, our Co-Chief Executive Officer, Chief Operating Officer and board member, Mr. Kajee, our Chief Financial Officer and Treasurer, and Mr. Talarico, our Chief Compliance Officer and Secretary, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC. The Investment Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or its affiliates may determine that we should invest side-by-side with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Investment Adviser’s allocation procedures. On June 13, 2017, the Investment Adviser received an exemptive order that permits the Company to participate in negotiated co-investment transactions with certain affiliates, in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to various conditions (the “Exemptive Order”). If the Company is unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although the Investment Adviser’s investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of the Investment Adviser.

Current wording

The Investment Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole or in part, with ours. For example, the Investment Adviser presently serves as investment adviser to SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured loans, including non-traditional asset-based loans and first lien loans, SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, SLR Private Credit BDC II LLC, an unlisted BDC focused on first lien senior secured floating rate loans, and SLR Secured Specialty Lending Fund, a non-exchange traded perpetual-life BDC whose principal focus is to invest in directly originated, senior secured loans to primarily U.S. based middle market companies across specialty finance investment strategies. In addition, Mr. Gross, our Chairman, Co-Chief Executive Officer and President, Mr. Spohler, our Co-Chief Executive Officer, Chief Operating Officer and board member, Mr. Kajee, our Chief Financial Officer and Treasurer, and Mr. Talarico, our Chief Compliance Officer and Secretary, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC, SLR Private Credit BDC II LLC and SLR Secured Specialty Lending Fund. The Investment Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or its affiliates may determine that we should invest side-by-side with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Investment Adviser’s allocation procedures. On June 13, 2017, the Investment Adviser received an exemptive order that permits the Company to participate in negotiated co-investment transactions with certain affiliates, in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to various conditions (the “Exemptive Order”). If the Company is unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although the Investment Adviser’s investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its stockholders could be adversely affected to the extent investment oppor…

Excerpt shortened here; the source contains the full paragraph.

Previous wording

Related party transactions may occur among us, SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL and SLR Equipment. These transactions may occur in the normal course of business. No administrative or other fees are paid to the Investment Adviser by SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL or SLR Equipment.

Current wording

Related party transactions may occur among us, SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, KBH, SLR Business Credit, SLR Healthcare ABL and SLR Equipment. These transactions may occur in the normal course of business. No administrative or other fees are paid to the Investment Adviser by SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, KBH, SLR Business Credit, SLR Healthcare ABL or SLR Equipment.